66 77

Cited 0 times in

말단비대증 환자에서 소마토스타틴 유사체 사용에 대한 권고안

Other Titles
 Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement 
Authors
 진상욱  ;  구철룡  ;  김병준  ;  김성운  ;  박경혜  ;  송기호  ;  오승준  ;  윤현구  ;  이은직  ;  이정민  ;  임정수  ;  김정희  ;  김광준  ;  진흥용  ;  김대중  ;  이경애  ;  문성수  ;  임동준  ;  신동엽  ;  김세화  ;  권민정  ;  김하영  ;  김진화  ;  김동선  ;  김종화 
Citation
 Korean Journal of Medicine, Vol.94(6) : 485-494, 2019-12 
Journal Title
 Korean Journal of Medicine 
ISSN
 1738-9364 
Issue Date
2019-12
Keywords
Acromegaly ; Somatostatin ; Octreotide ; Lanreotide ; Pasireotide
Abstract
Acromegaly is a chronic disorder caused by excessive growth hormone (GH) secretion. In most cases, the excess GH originates from GH-producing pituitary adenomas. Surgery is the preferred first-line treatment for patients with acromegaly, but medical management is considered when the disease persists after surgery or in cases where patients refuse surgery or are poor candidates for surgery. Somatostatin analogues are commonly used to treat acromegaly. The Korean Endocrine Society and the Korean Neuroendocrine Study Group have developed a position statement for the use of somatostatin analogues in the medical treatment of acromegaly. This position statement is based on evidence from the current literature and expert opinions. In the case of discrepancies among expert opinions, the experts voted to determine the recommended approach.
Files in This Item:
T201906465.pdf Download
DOI
10.3904/kjm.2019.94.6.485
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Ku, Cheol Ryong(구철룡) ORCID logo https://orcid.org/0000-0001-8693-9630
Kim, Kwang Joon(김광준) ORCID logo https://orcid.org/0000-0002-5554-8255
Shin, Dong Yeob(신동엽) ORCID logo https://orcid.org/0000-0003-1048-7978
Lee, Eun Jig(이은직) ORCID logo https://orcid.org/0000-0002-9876-8370
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/178109
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links